UPDATE – Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales Guidance
Provided By Globe Newswire
Last update: Jan 19, 2022
-- Fourth Quarter 2021 net sales for UPNEEQ grew by approximately 41% to $3.1 million compared to the third quarter 2021 --
-- Fourth Quarter 2022 net sales for UPNEEQ targeted to range from $20-$25 million --
Read more at globenewswire.com
